Overcoming the barriers that stand between promising bioactives and their full biological potential with the Dual Vector™ delivery system
Most scientific ideas begin in a laboratory.
This one did not.
It began with a question that emerged under circumstances few people will ever experience...
In the spring of 1986, Dr. Sergei Belyakov volunteered to the Army reserve for the emergency cleanup following the Chernobyl nuclear disaster, serving among the so-called “nuclear jumpers” or “the liquidators”, assigned to the most perilous tasks in the aftermath of the world’s worst nuclear catastrophe.
During an extremely intense and complex phase of the cleanup, the removal of highly radioactive debris from the roof of Reactor 3, Sergei reached a level of exhaustion he had never thought possible, even after years as a trained athlete.
He shed 12 kilograms, his physical and mental reserves collapsed, and apathy, loss of focus, and fading concentration – all consequences of relentless exposure to high radiation fields – began to erode his performance.

Dr. Sergei Belyakov, Chernobyl, Ukraine, 1986
When he finally returned home, he was only a shadow of the strong, energetic, vibrant man he had once been. Recovery took months, a slow climb back from the brink.
In the years that followed, Sergei found himself less preoccupied with how radiation had affected him personally than with the extraordinary capacity of the human body to withstand immense physical and psychological stress.
Some survivors of Chernobyl recovered with surprising speed. Others displayed remarkable resilience despite prolonged hardship. And some, tragically, did not. The differences were stark, too impossible to ignore.
Those observations lingered long after the disaster itself had passed into history. Gradually, they crystallized into a scientific question that would shape decades of his life’s work:
"What defines the limits of human resilience?
Can those limits be extended? And if so, how?"
The search for answers carried him far beyond life sciences – biochemistry and pharmaceutical chemistry. It eventually led into the realms of nutritional research, endogenous signalling molecules, natural and synthetic bioactives, formulation science… and ultimately into the broader challenges of vitality, longevity, and the pursuit of human endurance itself.
Over the years, one conclusion became increasingly clear. Nature has already produced an extraordinary collection of molecules capable of supporting many of the biological systems involved in stress adaptation, recovery and healthy ageing. Yet many of those molecules are constrained by the way they are accepted by our body.
That realization became the foundation of Fortivion Labs.
Long before it led to products, our work began with a question that first emerged some forty years ago: how can we help the body make better use of what nature has already provided?
Everything that followed, Dual Vector™, The Power of TRI™, and every formulation we develop today, grew from that original question. The human body has evolved remarkable mechanisms for adaptation, repair and recovery. We simply believe those mechanisms deserve better access tools.
Fortivion Labs was founded on a question first asked in 1986… and it is still being explored today.
* This defining episode in Dr. S. Belyakov’s life is recounted in his book "Liquidator – The Chernobyl Story" (World Scientific Publishing, 2019) and featured in the four-part original series "Disaster: The Chernobyl Meltdown" (CNN/National Geographic, 2026).
FORMULATION PHILOSOPHY
Formulation - Function - Effect
Volume-Driven: Relied on adding numerous ingredients to cover broad bases.
Additive Logic: Ingredients combined linearly without optimizing for cross-interaction.
Broad-Spectrum Opaque Formulations: General product with high formulation noise.
Flawed Dosage Rationale: Ingredients are either added in micro-doses below proven biological activity or in excessive mega-doses, overloading filtration systems and creating unpredictable metabolic interactions.
Efficacy-Driven: Minimal list of highly bioavailable actives working at functional doses for targeted efficacy.
Aiming for Complementary Effects and Synergy: Each bioactive complements and/or amplifies the effect of the others.
Zero Formulation Noise: Every single compound serves a precise, intentional role.
Calibrated Precision Dosing: Bioactives are delivered in exact, clinically effective amounts without excess, enabled by our proprietary delivery platform to maximize targeted biological impact.
DUAL VECTOR™ DELIVERY PLATFORM
A biomimetic and versatile delivery platform designed to protect diverse bioactives and extend their availability throughout progressive release during gastrointestinal transit
Unlike conventional delivery systems that rely primarily on particle size reduction or lipid vesicles, Dual Vector™ is built around a biomimetic ionic architecture designed to interact naturally with the gastrointestinal environment.
The platform is engineered to work in harmony with normal intestinal physiology, maximising opportunities for incorporated bioactives to reach the absorptive epithelium.
Most delivery technologies are developed for a specific class of compounds and require reformulation for each new ingredient.
Dual Vector™ is different: its carrier is synthesised first and can accommodate a broad range of hydrophilic and lipophilic compounds, botanical extracts, endogenous lipids and multi-ingredient formulations while maintaining high loading capacity. This makes Dual Vector™ a versatile formulation platform for diverse bioactives.
Dual Vector™ has been engineered to release incorporated bioactives progressively as the carrier moves through the gastrointestinal tract, prolonging their interaction with absorptive surfaces and maintaining availability across a broader absorption window, instead of concentrating the entire payload at a single point and limiting its opportunity for uptake.
For many sensitive bioactives, degradation begins long before absorption becomes possible. Oxygen, moisture, light and digestive enzymes can all reduce the amount of active compound ultimately available to the body.
Dual Vector™ carries incorporated bioactives in a protected form throughout manufacturing, storage and gastrointestinal transit, helping preserve their molecular integrity until release. This protective function is built directly into the platform’s design.

FORTIVION INSIGHTS
Two supplements may contain the same bioactive at the same dose and still present it to the body in very different ways. Stability, dispersion, wetting and intestinal availability all begin to matter before absorption is even possible.
This article explores why formulation is part of the science behind a supplement and how this understanding led to the development of Dual Vector™.
THE POWER OF TRI™
Every Fortivion formulation addresses a clearly defined health concern. We identify the physiological processes associated with it and then select bioactives that can contribute through relevant pathways.
Each formulation brings together three carefully selected bioactives supported by scientific evidence. Every ingredient has a distinct function and complements the contributions of the others without unnecessary duplication.
A focused formula delivers a targeted biological effect while keeping the overall bioactive load carefully controlled. It also makes products easier to combine and reduces the risk of unintentionally duplicating ingredients across a supplement regimen.
DELIVERED BY

Three bioactives. Three complementary roles
One precisely designed formulation